Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.52 |
| ▸ | EP300 | Q09472 | 2/20 | 0.50 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.38 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20530607 | 0.89 | CYP3A4 (0.49) | IDO1EP300KAT8MAOBCYP3A4 | |
| SCHEMBL19038923 | 0.89 | CYP3A4 (0.49) | IDO1MAOBCYP3A4CYP2A6MAPT | |
| SCHEMBL592709 | 0.82 | IDO1 (0.52) | IDO1EP300KAT8CYP3A4MAPT | |
| SCHEMBL19038909 | 0.81 | CYP3A4 (0.57) | MAOBCYP3A4CYP2A6MAPTMAOA | |
| SCHEMBL20530594 | 0.79 | IDO1 (0.59) | IDO1EP300KAT8MAOBCYP3A4 | |
| SCHEMBL1477239 | 0.77 | MAOB (0.56) | MAOBCYP3A4CYP2A6MAPTMAOA | |
| SCHEMBL20530602 | 0.76 | CA12 (0.50) | MAOBCYP3A4CYP2A6MAPTMAOA | |
| SCHEMBL1806065 | 0.76 | IDO1 (0.62) | IDO1EP300KAT8CYP3A4MAPT | |
| SCHEMBL2664436 | 0.75 | CYP3A4 (0.42) | IDO1MAOBCYP3A4CYP2A6MAPT | |
| SCHEMBL2650195 | 0.74 | CA12 (0.44) | MAOBCYP3A4CYP2A6MAPTLOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117873-B2 | Oxazine compound, composition, and cured product | DIC CORPORATION (JP) | 2021-09-14 | — | — | US | disclosed |
| US-11028059-B2 | Oxazine compound, composition and cured product | DIC CORPORATION (JP) | 2021-06-08 | — | — | US | disclosed |
| CN-108368217-B | Oxazine compound, composition and cured product | DIC株式会社 | 2021-05-07 | — | — | CN | disclosed |
| CN-108368216-B | Oxazine compound, composition and cured product | DIC株式会社 | 2020-09-18 | — | — | CN | disclosed |
| US-20180362480-A1 | OXAZINE COMPOUND, COMPOSITION, AND CURED PRODUCT | DIC CORPORATION (JP) | 2018-12-20 | — | — | US | disclosed |
| US-20180362477-A1 | OXAZINE COMPOUND, COMPOSITION AND CURED PRODUCT | DIC CORPORATION (JP) | 2018-12-20 | — | — | US | disclosed |
| EP-3388459-A1 | OXAZINE COMPOUND, COMPOSITION AND CURED PRODUCT | DIC Corporation (JP) | 2018-10-17 | — | — | EP | disclosed |
| EP-3388461-A1 | OXAZINE COMPOUND, COMPOSITION, AND CURED PRODUCT | DIC Corporation (JP) | 2018-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11028059-B2 | Oxazine compound, composition and cured product | KDM5A, WDR5, RNF5 | IDO1 1533/4885EP300 982/4885KAT8 739/4885 |
| US-20180362480-A1 | OXAZINE COMPOUND, COMPOSITION, AND CURED PRODUCT | KDM5A, WDR5, SMC4 | IDO1 1479/4885EP300 836/4885KAT8 746/4885 |
| US-11117873-B2 | Oxazine compound, composition, and cured product | KDM5A, WDR5, SMC4 | IDO1 1479/4885EP300 836/4885KAT8 746/4885 |
| US-20180362477-A1 | OXAZINE COMPOUND, COMPOSITION AND CURED PRODUCT | KDM5A, WDR5, RNF5 | IDO1 1533/4885EP300 982/4885KAT8 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.